Full history for every metric is available with a Kvantra account
Induction Healthcare Group PLC (INHC.L)
Key financial summary
Financials in GBP| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | £m | 0 | 0 | 1 | 7 | 13 | 14 | 13 |
| Operating profit | £m | -4 | -5 | |||||
| Net profit | £m | -3 | -4 | -8 | -8 | -17 | -3 | -5 |
| EPS reported | £ | -0.04 | -0.06 | |||||
| Operating cashflow per share | £ | -0.01 | -0.01 | |||||
| Capex per share | £ | 0.00 | 0.00 | |||||
| FCF per share | £ | -0.02 | -0.02 | |||||
| Free cash flow | £m | -1 | -1 | |||||
| Net debt | £m | -4 | -3 | |||||
| Book value equity | £m | 20 | 18 | |||||
| Book value per share | £ | 0.22 | 0.19 | |||||
| Number of shares | m | 92.78 | 93.85 | |||||
| DPS (TTM paid) | £ | 0.00 | 0.00 |
Financial summary
Financials in GBP| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 0.71 | 0.50 | |||||
| P/S LTM | x | 1.05 | 0.72 | |||||
| P/FCF LTM | x | -10.16 | -16.11 | |||||
| EV/EBITDA LTM | x | -65.14 | -7.75 | |||||
| EV/Sales LTM | x | 0.79 | 0.47 | |||||
| Earnings Yield LTM | % | -22.65% | -36.00% | |||||
| FCF Yield | % | -9.85% | -6.21% | |||||
| Quality | ||||||||
| ROE | % | -15.98% | -14.58% | |||||
| ROIC | % | -11.92% | -11.92% | |||||
| Operating margin | % | -30.79% | -30.79% | |||||
| Gross margin | % | 78.40% | 78.40% | |||||
| FCF/Sales | % | -10.38% | -10.38% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +5.93% | +8.09% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -24.84 | -24.70 | |||||
| Net Debt/EBITDA | x | 22.02 | 22.02 | |||||
| EBIT/Net interest | x | -382.00 | -382.00 | |||||
| Net debt/market cap | % | -25.66% | -33.97% | |||||
| Net debt/Equity | x | -0.18 | -0.17 | |||||
| Gross debt/equity | x | 0.00 | 0.00 | |||||
Company overview
Induction Healthcare Group PLC, founded in 2019 and based in London, United Kingdom, develops and provides cutting-edge software solutions to healthcare professionals and organizations globally, including in the UK, Europe, and the United States. Its comprehensive portfolio features Induction Switch, a secure communication platform that enables medical staff to bypass hospital switchboards, efficiently locate colleagues' extensions, respond to paging systems, and transmit instant, role-specific messages. Induction Zesty, a robust software-as-a-service (SaaS) platform, empowers patients to actively manage their healthcare by booking appointments, accessing clinical correspondence, maintaining personal health records, and securely sharing data with their care teams from any location. Another key offering is Induction Guidance, which provides a centralized system for creating, editing, and publishing local policies and clinical guidelines within healthcare settings. The company further offers the cloud-based Outpatient Parenteral Antimicrobial Therapy (OPAT) Management System, designed to streamline the management and monitoring of patients undergoing OPAT treatment. Induction Booking is an intuitive online platform facilitating appointment scheduling for patients, hospital staff, and care home personnel. For crucial data integration, Induction HealthStream efficiently processes patient demographic details, appointment information, and clinical records. Completing its suite, Induction Attend Anywhere facilitates secure video consultations between patients, service users, and healthcare providers, supporting hospitals, health systems, and other clients in delivering remote care.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Induction Healthcare Group PLC (INHC.L)
Induction Healthcare Group PLC, founded in 2019 and based in London, United Kingdom, develops and provides cutting-edge software solutions to healthcare professionals and organizations globally, including in the UK, Europe, and the United States. Its comprehensive portfolio features Induction Switch, a secure communication platform that enables medical staff to bypass hospital switchboards, efficiently locate colleagues' extensions, respond to paging systems, and transmit instant, role-specific messages. Induction Zesty, a robust software-as-a-service (SaaS) platform, empowers patients to actively manage their healthcare by booking appointments, accessing clinical correspondence, maintaining personal health records, and securely sharing data with their care teams from any location. Another key offering is Induction Guidance, which provides a centralized system for creating, editing, and publishing local policies and clinical guidelines within healthcare settings. The company further offers the cloud-based Outpatient Parenteral Antimicrobial Therapy (OPAT) Management System, designed to streamline the management and monitoring of patients undergoing OPAT treatment. Induction Booking is an intuitive online platform facilitating appointment scheduling for patients, hospital staff, and care home personnel. For crucial data integration, Induction HealthStream efficiently processes patient demographic details, appointment information, and clinical records. Completing its suite, Induction Attend Anywhere facilitates secure video consultations between patients, service users, and healthcare providers, supporting hospitals, health systems, and other clients in delivering remote care.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free